Methotrexate shows marginal clinical efficiency in early scleroderma.
Varga
John
J
Section of Rheumatology, University of Illinois at Chicago College of Medicine, Chicago, IL 60607-7171, USA. jvarga@uic.edu
D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D011446:Prospective Studies; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D007166:Immunosuppressive Agents; D008727:Methotrexate